TY  - GEN
AU  - Parra,H S
AU  - Tixi,L
AU  - Latteri,F
AU  - Bretti,S
AU  - Alloisio,M
AU  - Gravina,A
AU  - Lionetto,R
AU  - Bruzzi,P
AU  - Dani,C
AU  - Rosso,R
AU  - Cosso,M
AU  - Balzarini,L
AU  - Santoro,A
AU  - Ardizzoni,A
TI  - Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP)
SN  - 0008-543X
PY  - 2001///0830
KW  - Adult
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Cisplatin
KW  - administration & dosage
KW  - Doxorubicin
KW  - Female
KW  - Humans
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Male
KW  - Mesothelioma
KW  - drug therapy
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Pleural Neoplasms
KW  - Recombinant Proteins
KW  - Survival Rate
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1002/1097-0142(20010801)92:3<650::aid-cncr1366>3.0.co;2-0
ER  -